IN8bio appoints COO Kate Rochlin as President, effective immediately

IN8BIO, INC.

Kate Rochlin, current COO, assumes additional role of President effective Feb. 4, 2026.
Dr. Rochlin will continue serving as Chief Operating Officer of IN8bio.
Appointment made by Board on Feb. 4, 2026; no other executive changes.
No family relationships or transactions requiring disclosure under Regulation S-K.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.